United Kingdom Cancer Gene Market Insight
Published: 18 June 2026 | Report Format: Electronic (PDF)
The United Kingdom Cancer Gene Market is projected to grow at a CAGR of around 9.2%, driven by increasing adoption of precision oncology and growing utilization of genomic testing for personalized treatment strategies.
United Kingdom Cancer Gene Market Forecasts to 2035
- The United Kingdom Cancer Gene Market size was estimated at approximately USD 1.35 Billion in 2025.
- The market is expected to grow at a CAGR of around 9.1% from 2025 to 2035.
- The United Kingdom Cancer Gene Market is projected to reach approximately USD 3.25 Billion by 2035.
Notable Insight the United Kingdom Cancer Gene Market
- Based on gene type segmentation, Oncogenes and Tumor Suppressor Genes account for nearly 58% of market revenue in 2025, supported by increasing use of genomic profiling in cancer diagnosis and treatment planning.
- Based on application segmentation, Cancer Diagnostics represent approximately 49% of total market demand, driven by growing adoption of next-generation sequencing (NGS) and biomarker-based testing.
- The market is increasingly influenced by advances in precision medicine, with genomic testing incorporated into approximately 44% of oncology treatment pathways across the United Kingdom in 2025, supporting more personalized and targeted cancer therapies.
- Expanding investments in cancer research, companion diagnostics, and personalized medicine are supporting market growth, with molecular diagnostics accounting for approximately 36% of oncology-related healthcare spending.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
- Intelligent Market Research Based on AI for Semiconductors & Optoelectronics
Decisions Advisors offers intelligent market research which includes advanced analysis of infrared sensor technologies, optoelectronic semiconductors, AI-driven sensing solutions, and remote sensing. Our research identifies potential areas of business development, technology adoption rates, competitive position analysis, and important strategic changes in South Korea Remote Sensing Infrared Light Emitting Diode Market.
- Highly Effective Research Approaches with Accurate Forecast Analysis
The research process uses advanced methodologies such as primary research interview approaches, industry research, tracking the semiconductor value chain, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology forecasting. The study examines the demand for semiconductor solutions in automotive electronics, industrial automation, health care monitoring, and smart surveillance applications in South Korea.
- Highly Competitive Environment Analysis
In-depth analysis of key infrared LED players, optoelectronic semiconductor innovations, AI-enabled sensing solutions, product launch activities, and collaborations is included in the report. The report also covers semiconductor regulations, technology research and development analysis, smart sensor infrastructure, and new opportunities available in the South Korea Remote Sensing Infrared Light Emitting Diode Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Cancer Gene Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies United Kingdom Cancer Gene Market
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- QIAGEN N.V.
- Agilent Technologies, Inc.
- Exact Sciences Corporation
- Guardant Health, Inc.
- Bio-Rad Laboratories, Inc.
- Myriad Genetics, Inc.
- Invitae Corporation
Recent Developments:
- In May 2025, Illumina expanded its oncology genomics portfolio in the United Kingdom with advanced cancer sequencing solutions aimed at improving precision medicine applications.
- In February 2025, Roche introduced enhanced companion diagnostic capabilities to support targeted cancer therapies and personalized treatment selection across oncology centers in the UK.
Market Segmentation:
United Kingdom Cancer Gene Market, By Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray Technology
- In Situ Hybridization (ISH)
United Kingdom Cancer Gene Market, By Application
- Cancer Diagnostics
- Drug Discovery & Development
- Precision Medicine
- Research Applications
United Kingdom Cancer Gene Market, By End User
- Hospitals & Cancer Centers
- Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Expert Views:
The United Kingdom Cancer Gene Market is expected to witness substantial growth through 2035, supported by increasing cancer incidence, expanding genomic medicine programs, and growing demand for personalized oncology treatments. Advances in next-generation sequencing, liquid biopsy technologies, AI-assisted genomic analysis, and companion diagnostics are anticipated to improve cancer detection, treatment outcomes, and long-term market growth across the healthcare sector.
Author: Govind and Krishna By Decisions Advisors and Consulting